SCHEMBL7145771

SCHEMBL7145771

CC(=O)c1cc(S(N)(=O)=O)ccc1F

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 15/20 0.55
CA1 P00915 12/20 0.55
CA9 Q16790 8/20 0.55
CA12 O43570 2/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA5A P35218 1/20 0.50
CA7 P43166 1/20 0.50
CA14 Q9ULX7 1/20 0.50
CA5B Q9Y2D0 1/20 0.50
CHRNA7 P36544 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
SOS1 Q07889 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13687165 0.86 CA2 (0.59) CA2CA1CA9CA12CA4
SCHEMBL15836199 0.84 LMNA (0.50)
SCHEMBL283890 0.84 CYP3A4 (0.56) CA2CA1CA9CA12CA4
SCHEMBL15076431 0.84 CA2 (0.52) CA2CA1CA9CA12CA4
SCHEMBL18948542 0.82 CYP3A4 (0.41) CA2CA1CA9KDM4EMEN1
SCHEMBL7143573 0.81 CA1 (0.55) CA2CA1CA9CA12KDM4E
SCHEMBL13543311 0.81 CA2 (0.51) CA2CA1CA9CA12CA4
SCHEMBL13545187 0.81 CHRNA7 (0.49) CA2CA1CA9CA12CA4
SCHEMBL6151646 0.81 CA2 (0.56) CA2CA1CA9CA12CA4
SCHEMBL3362967 0.81 CA2 (0.58) CA2CA1CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1127479-C Sulfonylurea derivatives and their use in the control of interleukin-1 activity PFIZER (US) 2003-11-12 CN disclosed
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
US-6214882-B1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof SYNTHELABO (FR) 2001-04-10 US disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed
CN-1245490-A Sulfonyl urea derivatives and their use in control of interleukin-1 activity PFIZER (US) 2000-02-23 CN disclosed
EP-0964849-A1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER INC. (US) 1999-12-22 EP disclosed
WO-1998032733-A1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER INC. (US) 1998-07-30 WO disclosed